Skip to main content
Download PDF

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users

Advances in Therapy volume 32, page 387 (2015)Cite this article

The Original Article was published on 18 March 2015

Erratum to: Adv Ther (2015) 32:216–227 DOI 10.1007/s12325-015-0189-1

The authors wish to notify the readers that although the above mentioned article addressed different research questions and therefore evaluated different endpoints, the study employed a similar study design using the same sample of patients with nonvalvular atrial fibrillation (NVAF) treated with either rivaroxaban or warfarin as the study sample reported in a study published in Clinical Therapeutics by the present authors [1]. The current research focused on the economic evaluation of the effect of rivaroxaban versus warfarin among matched cohorts. Because the two articles were accepted for publication at the same time, the authors want to cross-reference both articles in the current addendum for clarity and transparency.

Reference

  1. Laliberté F, Cloutier M, Crivera C, et al. Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users. Clin Ther. 2015;37(3):554–62.

    Article  PubMed  Google Scholar 

Download references

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Author information

Affiliations

  1. Groupe d’analyse, Ltée, 1000 De La Gauchetière Ouest, Bureau 1200, Montréal, QC, H3B 4W5, Canada

    François Laliberté, Michel Cloutier, Guillaume Germain & Patrick Lefebvre

  2. Janssen Scientific Affairs, LLC, Raritan, NJ, USA

    Concetta Crivera, Winnie W. Nelson, William H. Olson, Jeffrey Schein & Julie Vanderpoel

Authors
  1. François Laliberté
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michel Cloutier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Concetta Crivera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Winnie W. Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. William H. Olson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jeffrey Schein
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Julie Vanderpoel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Guillaume Germain
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Patrick Lefebvre
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to François Laliberté.

Additional information

The online version of the original article can be found under doi:10.1007/s12325-015-0189-1.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Laliberté, F., Cloutier, M., Crivera, C. et al. Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users. Adv Ther 32, 387 (2015). https://doi.org/10.1007/s12325-015-0202-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-015-0202-8